• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

人内皮细胞衍生的外泌体 microRNA-99a/b 通过抑制 mTOR 表达在脓毒症期间驱动持续的炎症反应。

Human endothelial cell-derived exosomal microRNA-99a/b drives a sustained inflammatory response during sepsis by inhibiting mTOR expression.

机构信息

Cardiovascular Infection Research Group, Dublin, Ireland.

School of Pharmacy and Biomolecular Sciences, RCSI University of Medicine and Health Sciences, Dublin, Ireland.

出版信息

Front Cell Infect Microbiol. 2022 Aug 18;12:854126. doi: 10.3389/fcimb.2022.854126. eCollection 2022.

DOI:10.3389/fcimb.2022.854126
PMID:36061862
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9434345/
Abstract

The pathophysiology of sepsis and its accompanying hyper-inflammatory response are key events that lead to multi-organ failure and death. A growing body of literature now suggests that the vascular endothelium plays a critical role in driving early events of sepsis progression. In this study, we demonstrate how endothelial-derived exosomes contribute to a successive pro-inflammatory phenotype of monocytes. Exosomes isolated from infected endothelial cells drive both CD11b and MHCII expression in monocytes and contribute dysregulated cytokine production. Conversely, healthy endothelial exosomes had no major effect. microRNA (miRNA) profiling of exosomes identified miR-99 upregulation which we hypothesised as driving this phenotypic change through mechanistic target of rapamycin (mTOR). Knockdown of mTOR with miR-99a and miR-99b mimetics in infected monocytes increased IL-6 and decreased IL-10 production. Interestingly, inhibition of miRNAs with antagomirs has the opposing effect. Collectively, endothelial exosomes are driving a pro-inflammatory phenotype in monocytes through dysregulated expression of miR-99a and miR-99b.

摘要

脓毒症的病理生理学及其伴随的过度炎症反应是导致多器官衰竭和死亡的关键事件。越来越多的文献表明,血管内皮在推动脓毒症进展的早期事件中起着关键作用。在这项研究中,我们展示了内皮细胞来源的外泌体如何导致单核细胞连续的促炎表型。从 感染的内皮细胞中分离的外泌体驱动单核细胞中 CD11b 和 MHCII 的表达,并导致细胞因子产生失调。相反,健康的内皮细胞外泌体没有产生主要影响。外泌体的 microRNA (miRNA) 谱鉴定出 miR-99 的上调,我们假设通过雷帕霉素 (mTOR) 的机制靶点驱动这种表型变化。用 miR-99a 和 miR-99b 模拟物敲低感染的单核细胞中的 mTOR,增加了 IL-6 的产生,减少了 IL-10 的产生。有趣的是,用反义寡核苷酸抑制 miRNAs 则有相反的效果。总之,内皮细胞外泌体通过 miR-99a 和 miR-99b 的失调表达,驱动单核细胞中的促炎表型。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f2cd/9434345/3a85e8ba7a2b/fcimb-12-854126-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f2cd/9434345/855435d259f2/fcimb-12-854126-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f2cd/9434345/1318e025c882/fcimb-12-854126-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f2cd/9434345/26f4e2f3a6cf/fcimb-12-854126-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f2cd/9434345/65ec13e44c39/fcimb-12-854126-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f2cd/9434345/3a85e8ba7a2b/fcimb-12-854126-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f2cd/9434345/855435d259f2/fcimb-12-854126-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f2cd/9434345/1318e025c882/fcimb-12-854126-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f2cd/9434345/26f4e2f3a6cf/fcimb-12-854126-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f2cd/9434345/65ec13e44c39/fcimb-12-854126-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f2cd/9434345/3a85e8ba7a2b/fcimb-12-854126-g005.jpg

相似文献

1
Human endothelial cell-derived exosomal microRNA-99a/b drives a sustained inflammatory response during sepsis by inhibiting mTOR expression.人内皮细胞衍生的外泌体 microRNA-99a/b 通过抑制 mTOR 表达在脓毒症期间驱动持续的炎症反应。
Front Cell Infect Microbiol. 2022 Aug 18;12:854126. doi: 10.3389/fcimb.2022.854126. eCollection 2022.
2
MicroRNA-99a inhibits insulin-induced proliferation, migration, dedifferentiation, and rapamycin resistance of vascular smooth muscle cells by inhibiting insulin-like growth factor-1 receptor and mammalian target of rapamycin.微小RNA-99a通过抑制胰岛素样生长因子-1受体和雷帕霉素靶蛋白来抑制胰岛素诱导的血管平滑肌细胞增殖、迁移、去分化及雷帕霉素抗性。
Biochem Biophys Res Commun. 2017 Apr 29;486(2):414-422. doi: 10.1016/j.bbrc.2017.03.056. Epub 2017 Mar 15.
3
MicroRNA-100 shuttled by mesenchymal stem cell-derived exosomes suppresses in vitro angiogenesis through modulating the mTOR/HIF-1α/VEGF signaling axis in breast cancer cells.间充质干细胞来源的外泌体携带 microRNA-100 通过调控乳腺癌细胞中的 mTOR/HIF-1α/VEGF 信号轴抑制体外血管生成。
Cell Oncol (Dordr). 2017 Oct;40(5):457-470. doi: 10.1007/s13402-017-0335-7. Epub 2017 Jul 24.
4
Exosomal miR-99a-5p is elevated in sera of ovarian cancer patients and promotes cancer cell invasion by increasing fibronectin and vitronectin expression in neighboring peritoneal mesothelial cells.外泌体 miR-99a-5p 在卵巢癌患者血清中升高,并通过增加邻近腹膜间皮细胞中纤连蛋白和 vitronectin 的表达促进癌细胞侵袭。
BMC Cancer. 2018 Nov 5;18(1):1065. doi: 10.1186/s12885-018-4974-5.
5
Increased miR-124-3p in microglial exosomes following traumatic brain injury inhibits neuronal inflammation and contributes to neurite outgrowth their transfer into neurons.创伤性脑损伤后小胶质细胞外泌体中 miR-124-3p 的增加抑制神经元炎症,促进轴突生长及其向神经元的转移。
FASEB J. 2018 Jan;32(1):512-528. doi: 10.1096/fj.201700673R. Epub 2017 Sep 21.
6
Exosomal microRNA-107 reverses chemotherapeutic drug resistance of gastric cancer cells through HMGA2/mTOR/P-gp pathway.外泌体 microRNA-107 通过 HMGA2/mTOR/P-gp 通路逆转胃癌细胞的化疗耐药性。
BMC Cancer. 2021 Dec 2;21(1):1290. doi: 10.1186/s12885-021-09020-y.
7
MiR-99a antitumor activity in human breast cancer cells through targeting of mTOR expression.MiR-99a通过靶向mTOR表达在人乳腺癌细胞中的抗肿瘤活性。
PLoS One. 2014 Mar 17;9(3):e92099. doi: 10.1371/journal.pone.0092099. eCollection 2014.
8
microRNA-27b shuttled by mesenchymal stem cell-derived exosomes prevents sepsis by targeting JMJD3 and downregulating NF-κB signaling pathway.间充质干细胞来源的外泌体携带 microRNA-27b 通过靶向 JMJD3 和下调 NF-κB 信号通路来预防脓毒症。
Stem Cell Res Ther. 2021 Jan 7;12(1):14. doi: 10.1186/s13287-020-02068-w.
9
NF-κB-Regulated miR-99a Modulates Endothelial Cell Inflammation.核因子-κB调控的微小RNA-99a调节内皮细胞炎症反应。
Mediators Inflamm. 2016;2016:5308170. doi: 10.1155/2016/5308170. Epub 2016 Jun 14.
10
MiR-99a Inhibits Cell Proliferation and Tumorigenesis through Targeting mTOR in Human Anaplastic Thyroid Cancer.微小RNA-99a通过靶向雷帕霉素靶蛋白抑制人间变性甲状腺癌的细胞增殖和肿瘤发生。
Asian Pac J Cancer Prev. 2015;16(12):4937-44. doi: 10.7314/apjcp.2015.16.12.4937.

引用本文的文献

1
Pathogenic and therapeutic roles of extracellular vesicles in sepsis.细胞外囊泡在脓毒症中的致病及治疗作用
Front Immunol. 2025 Feb 4;16:1535427. doi: 10.3389/fimmu.2025.1535427. eCollection 2025.
2
Pathologic function and therapeutic potential of extracellular vesicle miRNA in sepsis.细胞外囊泡微小RNA在脓毒症中的病理功能及治疗潜力
Front Pharmacol. 2024 Dec 18;15:1452276. doi: 10.3389/fphar.2024.1452276. eCollection 2024.
3
Exosome-Derived microRNA: Potential Target for Diagnosis and Treatment of Sepsis.外泌体衍生 microRNA:脓毒症诊断和治疗的潜在靶点。

本文引用的文献

1
Circulating Exosomes Are Strongly Involved in SARS-CoV-2 Infection.循环外泌体与严重急性呼吸综合征冠状病毒2(SARS-CoV-2)感染密切相关。
Front Mol Biosci. 2021 Feb 22;8:632290. doi: 10.3389/fmolb.2021.632290. eCollection 2021.
2
MicroRNA-155: Regulation of Immune Cells in Sepsis.miR-155:脓毒症中免疫细胞的调控。
Mediators Inflamm. 2021 Jan 8;2021:8874854. doi: 10.1155/2021/8874854. eCollection 2021.
3
Global, regional, and national sepsis incidence and mortality, 1990-2017: analysis for the Global Burden of Disease Study.
J Immunol Res. 2024 Jul 25;2024:4481452. doi: 10.1155/2024/4481452. eCollection 2024.
4
Extracellular vesicles and endothelial dysfunction in infectious diseases.传染病中的细胞外囊泡与内皮功能障碍
J Extracell Biol. 2024 Apr 12;3(4):e148. doi: 10.1002/jex2.148. eCollection 2024 Apr.
5
An overview of the mechanisms and potential roles of extracellular vesicles in septic shock.细胞外囊泡在脓毒性休克中的作用机制及潜在作用概述。
Front Immunol. 2024 Jan 26;14:1324253. doi: 10.3389/fimmu.2023.1324253. eCollection 2023.
6
A bibliometric analysis of exosomes in sepsis from 2004 to 2022.2004 年至 2022 年脓毒症中外泌体的文献计量分析。
Medicine (Baltimore). 2023 Aug 4;102(31):e34613. doi: 10.1097/MD.0000000000034613.
7
Physiological and pathological consequences of exosomes at the blood-brain-barrier interface.血脑屏障界面外泌体的生理和病理后果。
Cell Commun Signal. 2023 May 19;21(1):118. doi: 10.1186/s12964-023-01142-z.
8
New Markers for Cardiovascular Disease in Psoriatic Patients: Preliminary Study on Monocyte Phenotype, ADAMTS7, and mTOR Activity.银屑病患者心血管疾病的新标志物:单核细胞表型、ADAMTS7和mTOR活性的初步研究
Metabolites. 2023 Jan 11;13(1):116. doi: 10.3390/metabo13010116.
全球、地区和国家脓毒症发病率和死亡率,1990-2017 年:全球疾病负担研究分析。
Lancet. 2020 Jan 18;395(10219):200-211. doi: 10.1016/S0140-6736(19)32989-7.
4
Circulating MicroRNAs in Cancer: Potential and Challenge.癌症中的循环微小RNA:潜力与挑战
Front Genet. 2019 Jul 18;10:626. doi: 10.3389/fgene.2019.00626. eCollection 2019.
5
Exosomes Derived From Septic Mouse Serum Modulate Immune Responses via Exosome-Associated Cytokines.来源脓毒症小鼠血清的外泌体通过外泌体相关细胞因子调节免疫反应。
Front Immunol. 2019 Jul 12;10:1560. doi: 10.3389/fimmu.2019.01560. eCollection 2019.
6
Sepsis: Inflammation Is a Necessary Evil.脓毒症:炎症是一把双刃剑。
Front Cell Dev Biol. 2019 Jun 20;7:108. doi: 10.3389/fcell.2019.00108. eCollection 2019.
7
Exosomal miRNA-19b-3p of tubular epithelial cells promotes M1 macrophage activation in kidney injury.肾小管上皮细胞来源的外泌体 miR-19b-3p 促进肾损伤中 M1 巨噬细胞的活化。
Cell Death Differ. 2020 Jan;27(1):210-226. doi: 10.1038/s41418-019-0349-y. Epub 2019 May 16.
8
Cytokine Targeting by miRNAs in Autoimmune Diseases.miRNAs 在自身免疫性疾病中的细胞因子靶向作用
Front Immunol. 2019 Jan 29;10:15. doi: 10.3389/fimmu.2019.00015. eCollection 2019.
9
Author Correction: An NF-κB-microRNA regulatory network tunes macrophage inflammatory responses.作者更正:一个NF-κB-微小RNA调控网络调节巨噬细胞炎症反应。
Nat Commun. 2018 Aug 16;9(1):3338. doi: 10.1038/s41467-018-05720-5.
10
MiR-99a Enhances the Radiation Sensitivity of Non-Small Cell Lung Cancer by Targeting mTOR.微小RNA-99a通过靶向雷帕霉素靶蛋白增强非小细胞肺癌的放射敏感性。
Cell Physiol Biochem. 2018;46(2):471-481. doi: 10.1159/000488615. Epub 2018 Mar 26.